Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Obstructive Lung Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 188 articles:
HTML format



Single Articles


    January 2022
  1. KUMARI MV, Amarasiri L, Rajindrajith S, Devanarayana NM, et al
    Gastric motility and pulmonary function in children with functional abdominal pain disorders and asthma: A pathophysiological study.
    PLoS One. 2022;17:e0262086.
    PubMed     Abstract available


  2. MULUGETA T, Ayele T, Zeleke G, Tesfay G, et al
    Asthma control and its predictors in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0262566.
    PubMed     Abstract available


  3. ROH JH, Lee H, Yun-Jeong B, Park CS, et al
    A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adults.
    PLoS One. 2022;17:e0262715.
    PubMed     Abstract available


  4. CELIK E, Nelles C, Kottlors J, Fervers P, et al
    Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection.
    PLoS One. 2022;17:e0263261.
    PubMed     Abstract available


  5. MCNAMARA PS, Clayton D, Burchett C, Compton V, et al
    Humidified and standard oxygen therapy in acute severe asthma in children (HUMOX): A pilot randomised controlled trial.
    PLoS One. 2022;17:e0263044.
    PubMed     Abstract available


  6. HAMZEH H, Spencer S, Kelly C
    Development of a core outcome set and outcome measurement set for physiotherapy trials in adults with Bronchiectasis (COS-PHyBE study): A protocol.
    PLoS One. 2022;17:e0263695.
    PubMed     Abstract available


  7. KNUDSEN KS, Lehmann S, Nielsen R, Tangedal S, et al
    The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    PLoS One. 2022;17:e0262082.
    PubMed     Abstract available


  8. REINHART JM, de Oliveira GAR, Forsythe L, Li Z, et al
    Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.
    PLoS One. 2022;17:e0262336.
    PubMed     Abstract available


  9. BAKSHI A, Van Doren A, Maser C, Aubin K, et al
    Identifying Louisiana communities at the crossroads of environmental and social vulnerability, COVID-19, and asthma.
    PLoS One. 2022;17:e0264336.
    PubMed     Abstract available


  10. HERAGANAHALLY SS, Howarth T, Sorger L, Ben Saad H, et al
    Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease.
    PLoS One. 2022;17:e0263744.
    PubMed     Abstract available


  11. SAIPHOKLANG N, Pugongchai A, Leelasittikul K
    Comparison between 20 and 30 meters in walkway length affecting the 6-minute walk test in patients with chronic obstructive pulmonary disease: A randomized crossover study.
    PLoS One. 2022;17:e0262238.
    PubMed     Abstract available


  12. AUGUSTIN IML, Franssen FME, Houben-Wilke S, Janssen DJA, et al
    Multidimensional outcome assessment of pulmonary rehabilitation in traits-based clusters of COPD patients.
    PLoS One. 2022;17:e0263657.
    PubMed     Abstract available


  13. WEN S, Yuan G, Li C, Xiong Y, et al
    High cellulose dietary intake relieves asthma inflammation through the intestinal microbiome in a mouse model.
    PLoS One. 2022;17:e0263762.
    PubMed     Abstract available


  14. MARCALO R, Neto S, Pinheiro M, Rodrigues AJ, et al
    Evaluation of the genetic risk for COVID-19 outcomes in COPD and differences among worldwide populations.
    PLoS One. 2022;17:e0264009.
    PubMed     Abstract available


  15. WINNICA DE, Monzon A, Ye S, Vladar EK, et al
    Airway epithelial Paraoxonase-2 in obese asthma.
    PLoS One. 2022;17:e0261504.
    PubMed     Abstract available


  16. HYODO K, Masuko H, Oshima H, Shigemasa R, et al
    Common exacerbation-prone phenotypes across asthma and chronic obstructive pulmonary disease (COPD).
    PLoS One. 2022;17:e0264397.
    PubMed     Abstract available


  17. BUSHONG A, McKeon T, Regina Boland M, Field J, et al
    Publicly available data reveals association between asthma hospitalizations and unconventional natural gas development in Pennsylvania.
    PLoS One. 2022;17:e0265513.
    PubMed     Abstract available


  18. SUNDH J, Palm A, Wahlberg J, Runold M, et al
    Impact of covid-19 on long-term oxygen therapy 2020: A nationwide study in Sweden.
    PLoS One. 2022;17:e0266367.
    PubMed     Abstract available


  19. CAVALCANTI JD, Fregonezi GAF, Sarmento AJ, Bezerra T, et al
    Electrical activity and fatigue of respiratory and locomotor muscles in obstructive respiratory diseases during field walking test.
    PLoS One. 2022;17:e0266365.
    PubMed     Abstract available


  20. JEGANATHAN V, Knight S, Bricknell M, Ridgers A, et al
    Impact of smoking status and chronic obstructive pulmonary disease on pulmonary complications post lung cancer surgery.
    PLoS One. 2022;17:e0266052.
    PubMed     Abstract available


  21. ZHANG C, Li W, Li X, Wan D, et al
    Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor.
    PLoS One. 2022;17:e0266608.
    PubMed     Abstract available


  22. STEVENS DR, Rohn MCH, Hinkle SN, Williams AD, et al
    Maternal body composition and gestational weight gain in relation to asthma control during pregnancy.
    PLoS One. 2022;17:e0267122.
    PubMed     Abstract available


  23. CASSELBRANT A, Fedorowski A, Frantz S, Engstrom G, et al
    Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease.
    PLoS One. 2022;17:e0264376.
    PubMed     Abstract available


  24. SVENDSEN CD, Kuiper KKJ, Ostridge K, Larsen TH, et al
    Factors associated with coronary heart disease in COPD patients and controls.
    PLoS One. 2022;17:e0265682.
    PubMed     Abstract available


  25. ASHEBIR G, Nigussie H, Glagn M, Beyene K, et al
    Determinants of hyperemesis gravidarum among pregnant women attending health care service in public hospitals of Southern Ethiopia.
    PLoS One. 2022;17:e0266054.
    PubMed     Abstract available


  26. CHAN AHY, Foot H, Pearce CJ, Horne R, et al
    Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0265715.
    PubMed     Abstract available


  27. KASO AW, Agero G, Hurissa Z, Kaso T, et al
    Survival analysis of COVID-19 patients in Ethiopia: A hospital-based study.
    PLoS One. 2022;17:e0268280.
    PubMed     Abstract available


  28. FUTAMURA M, Hiramitsu Y, Kamioka N, Yamaguchi C, et al
    Prevalence of infantile wheezing and eczema in a metropolitan city in Japan: A complete census survey.
    PLoS One. 2022;17:e0268092.
    PubMed     Abstract available


  29. KOLDEWEIJ C, Appelbaum N, Rodriguez Gonzalvez C, Nijman J, et al
    Mind the gap: Mapping variation between national and local clinical practice guidelines for acute paediatric asthma from the United Kingdom and the Netherlands.
    PLoS One. 2022;17:e0267445.
    PubMed     Abstract available


  30. HOFER F, Schreyogg J, Stargardt T
    Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany: Evidence from the first three years.
    PLoS One. 2022;17:e0267952.
    PubMed     Abstract available


  31. MARTINSEN EMH, Eagan TML, Wiker HG, Leiten EO, et al
    A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease.
    PLoS One. 2022;17:e0267195.
    PubMed     Abstract available


  32. ALQAHTANI JS
    Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019.
    PLoS One. 2022;17:e0268772.
    PubMed     Abstract available


  33. PEROSSI L, Holtz M, Santos DOD, Perossi J, et al
    Increased airway resistance can be related to the decrease in the functional capacity in obese women.
    PLoS One. 2022;17:e0267546.
    PubMed     Abstract available


  34. MAJELLANO EC, Clark VL, McLoughlin RF, Gibson PG, et al
    Using a knowledge translation framework to identify health care professionals' perceived barriers and enablers for personalised severe asthma care.
    PLoS One. 2022;17:e0269038.
    PubMed     Abstract available


  35. PATEL P, Muhammad T, Sahoo H
    Morbidity status and changes in difficulty in activities of daily living among older adults in India: A panel data analysis.
    PLoS One. 2022;17:e0269388.
    PubMed     Abstract available


  36. FENG S, Yuan J, Zhao D, Li R, et al
    Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology.
    PLoS One. 2022;17:e0269087.
    PubMed     Abstract available


    January 2021
  37. BAE WD, Kim S, Park CS, Alkobaisi S, et al
    Performance improvement of machine learning techniques predicting the association of exacerbation of peak expiratory flow ratio with short term exposure level to indoor air quality using adult asthmatics clustered data.
    PLoS One. 2021;16:e0244233.
    PubMed     Abstract available


  38. RUTTEN B, Young S, Rhedin M, Olsson M, et al
    Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarker.
    PLoS One. 2021;16:e0246627.
    PubMed     Abstract available


  39. XU H, Tong L, Gao P, Hu Y, et al
    Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis.
    PLoS One. 2021;16:e0237620.
    PubMed     Abstract available


  40. SCHONFELD D, Arias S, Bossio JC, Fernandez H, et al
    Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database.
    PLoS One. 2021;16:e0246793.
    PubMed     Abstract available


  41. BOSE S, Kenyon CC, Masino AJ
    Personalized prediction of early childhood asthma persistence: A machine learning approach.
    PLoS One. 2021;16:e0247784.
    PubMed     Abstract available


  42. COSTA PPC, Waller SB, Dos Santos GR, Gondim FL, et al
    Anti-asthmatic effect of nitric oxide metallo-donor FOR811A [cis-[Ru(bpy)2(2-MIM)(NO)](PF6)3] in the respiratory mechanics of Swiss mice.
    PLoS One. 2021;16:e0248394.
    PubMed     Abstract available


  43. YAMADA H, Nakajima M, Matsuyama M, Morishima Y, et al
    Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma.
    PLoS One. 2021;16:e0248305.
    PubMed     Abstract available


  44. FONSECA LGA, Florencio RB, Lima INDF, Peroni Gualdi L, et al
    Time trend of Brazilian hospital admissions and deaths due to asthma among children and teenagers, 1998-2019.
    PLoS One. 2021;16:e0248472.
    PubMed     Abstract available


  45. ERASO I, Sangiovanni S, Morales EI, Fernandez-Trujillo L, et al
    Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis.
    PLoS One. 2021;16:e0247871.
    PubMed     Abstract available


  46. LAM J, Koustas E, Sutton P, Padula AM, et al
    Exposure to formaldehyde and asthma outcomes: A systematic review, meta-analysis, and economic assessment.
    PLoS One. 2021;16:e0248258.
    PubMed     Abstract available


  47. JOHNATHAN M, Muhamad SA, Gan SH, Stanslas J, et al
    Lignosus rhinocerotis Cooke Ryvarden ameliorates airway inflammation, mucus hypersecretion and airway hyperresponsiveness in a murine model of asthma.
    PLoS One. 2021;16:e0249091.
    PubMed     Abstract available


  48. BOEHNE C, Behrendt AK, Meyer-Bahlburg A, Boettcher M, et al
    Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma.
    PLoS One. 2021;16:e0249605.
    PubMed     Abstract available


  49. HAHN DL
    Chlamydia pneumoniae and chronic asthma: Updated systematic review and meta-analysis of population attributable risk.
    PLoS One. 2021;16:e0250034.
    PubMed     Abstract available


  50. SAIJO Y, Yoshioka E, Sato Y, Miyamoto T, et al
    Parental educational level and childhood wheezing and asthma: A prospective cohort study from the Japan Environment and Children's Study.
    PLoS One. 2021;16:e0250255.
    PubMed     Abstract available


  51. EMMERSON KM, Silver JD, Thatcher M, Wain A, et al
    Atmospheric modelling of grass pollen rupturing mechanisms for thunderstorm asthma prediction.
    PLoS One. 2021;16:e0249488.
    PubMed     Abstract available


  52. VELLA G, Ritzmann F, Wolf L, Kamyschnikov A, et al
    IL-17C contributes to NTHi-induced inflammation and lung damage in experimental COPD and is present in sputum during acute exacerbations.
    PLoS One. 2021;16:e0243484.
    PubMed     Abstract available


  53. CHOI WS, Kang HS, Kim HJ, Lee WT, et al
    Vinpocetine alleviates lung inflammation via macrophage inflammatory protein-1beta inhibition in an ovalbumin-induced allergic asthma model.
    PLoS One. 2021;16:e0251012.
    PubMed     Abstract available


  54. KHAN MS, Dogra R, Miriyala LKV, Salman FNU, et al
    Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio.
    PLoS One. 2021;16:e0250400.
    PubMed     Abstract available


  55. SALAMEH L, Mahboub B, Khamis A, Alsharhan M, et al
    Asthma severity as a contributing factor to cancer incidence: A cohort study.
    PLoS One. 2021;16:e0250430.
    PubMed     Abstract available


  56. LI X, Zhong X, Wang Y, Zeng X, et al
    Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250602.
    PubMed     Abstract available


  57. KWIZERA R, Bongomin F, Olum R, Worodria W, et al
    Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda.
    PLoS One. 2021;16:e0252553.
    PubMed     Abstract available


  58. RASCH-HALVORSEN O, Hassel E, Brumpton BM, Jenssen H, et al
    Lung function and peak oxygen uptake in chronic obstructive pulmonary disease phenotypes with and without emphysema.
    PLoS One. 2021;16:e0252386.
    PubMed     Abstract available


  59. SCHAFER S, Wang K, Sundling F, Yang J, et al
    Modelling maternal and perinatal risk factors to predict poorly controlled childhood asthma.
    PLoS One. 2021;16:e0252215.
    PubMed     Abstract available


  60. CLEMENS KK, Le B, Ouedraogo AM, Mackenzie C, et al
    Childhood food insecurity and incident asthma: A population-based cohort study of children in Ontario, Canada.
    PLoS One. 2021;16:e0252301.
    PubMed     Abstract available


  61. CRESPO-LESSMANN A, Bernal S, Del Rio E, Rojas E, et al
    Association of the CFTR gene with asthma and airway mucus hypersecretion.
    PLoS One. 2021;16:e0251881.
    PubMed     Abstract available


  62. RENNERT-MAY E, Leal J, Thanh NX, Lang E, et al
    The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study.
    PLoS One. 2021;16:e0252441.
    PubMed     Abstract available


  63. OZKAN M, Eskiocak YC, Wingender G
    Macrophage and dendritic cell subset composition can distinguish endotypes in adjuvant-induced asthma mouse models.
    PLoS One. 2021;16:e0250533.
    PubMed     Abstract available


  64. COMPAGNON A, Nguyen L, Antoun Z, Stach B, et al
    Management of acute COPD exacerbations in France: A qualitative survey in a private practice setting.
    PLoS One. 2021;16:e0245373.
    PubMed     Abstract available


  65. WARDYN PM, de Broucker V, Chenivesse C, Sobaszek A, et al
    Assessing the applicability of the new Global Lung Function Initiative reference values for the diffusing capacity of the lung for carbon monoxide in a large population set.
    PLoS One. 2021;16:e0245434.
    PubMed     Abstract available


  66. ARIDGIDES D, Dessaint J, Atkins G, Carroll J, et al
    Safety of research bronchoscopy with BAL in stable adult patients with cystic fibrosis.
    PLoS One. 2021;16:e0245696.
    PubMed     Abstract available


  67. VASILEIADOU S, Ekerljung L, Bjerg A, Goksor E, et al
    Asthma increased in young adults from 2008-2016 despite stable allergic rhinitis and reduced smoking.
    PLoS One. 2021;16:e0253322.
    PubMed     Abstract available


  68. ALVES AFF, Miranda JRA, Reis F, Oliveira AA, et al
    Automatic algorithm for quantifying lung involvement in patients with chronic obstructive pulmonary disease, infection with SARS-CoV-2, paracoccidioidomycosis and no lung disease patients.
    PLoS One. 2021;16:e0251783.
    PubMed     Abstract available


  69. GRLE SP, Lampalo M, Cincar SS, Kardum LB, et al
    Attitudes of Croatian pulmonologists concerning obstacles to earlier, more appropriate use of biologics in severe asthma: Survey results.
    PLoS One. 2021;16:e0253468.
    PubMed     Abstract available


  70. SEN P, Majumdar U, Zein J, Hatipoglu U, et al
    Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic's COVID-19 registry.
    PLoS One. 2021;16:e0252576.
    PubMed     Abstract available


  71. ZAFIRAH Y, Lin YK, Andhikaputra G, Deng LW, et al
    Mortality and morbidity of asthma and chronic obstructive pulmonary disease associated with ambient environment in metropolitans in Taiwan.
    PLoS One. 2021;16:e0253814.
    PubMed     Abstract available


  72. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Variable effects of underlying diseases on the prognosis of patients with COVID-19.
    PLoS One. 2021;16:e0254258.
    PubMed     Abstract available


  73. STEARNS K, Goldklang M, Xiao R, Zelonina T, et al
    Knockdown of Alpha-1 Antitrypsin with antisense oligonucleotide does not exacerbate smoke induced lung injury.
    PLoS One. 2021;16:e0246040.
    PubMed     Abstract available


  74. SEOL HY, Shrestha P, Muth JF, Wi CI, et al
    Artificial intelligence-assisted clinical decision support for childhood asthma management: A randomized clinical trial.
    PLoS One. 2021;16:e0255261.
    PubMed     Abstract available


  75. ALUPO P, Wosu AC, Mahofa A, Mugenyi L, et al
    Incidence and predictors of COPD mortality in Uganda: A 2-year prospective cohort study.
    PLoS One. 2021;16:e0246850.
    PubMed     Abstract available


  76. ALQAHTANI JS, Oyelade T, Aldhahir AM, Mendes RG, et al
    Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0255659.
    PubMed     Abstract available


  77. LIU T, Yang D, Liu C
    Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting beta2-agonist in patients with persistent asthma: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0257075.
    PubMed     Abstract available


  78. PEREZ-CRUZ M, Kone B, Porte R, Carnoy C, et al
    The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice.
    PLoS One. 2021;16:e0236216.
    PubMed     Abstract available


  79. TURNIER L, Eakin M, Woo H, Dransfield M, et al
    The influence of social support on COPD outcomes mediated by depression.
    PLoS One. 2021;16:e0245478.
    PubMed     Abstract available


  80. LIU J, Huang J, Liu H, Chen C, et al
    Elevated serum 4HNE plus decreased serum thioredoxin: Unique feature and implications for acute exacerbation of chronic obstructive pulmonary disease.
    PLoS One. 2021;16:e0245810.
    PubMed     Abstract available


  81. MARTINSEN EMH, Eagan TML, Leiten EO, Haaland I, et al
    The pulmonary mycobiome-A study of subjects with and without chronic obstructive pulmonary disease.
    PLoS One. 2021;16:e0248967.
    PubMed     Abstract available


  82. CAMUS-GARCIA E, Gonzalez-Gonzalez AI, Heijmans M, Nino de Guzman E, et al
    Self-management interventions for adults living with Chronic Obstructive Pulmonary Disease (COPD): The development of a Core Outcome Set for COMPAR-EU project.
    PLoS One. 2021;16:e0247522.
    PubMed     Abstract available


  83. CIUDAD-GUTIERREZ P, Fernandez-Rubio B, Guisado-Gil AB
    Gender bias in clinical trials of biological agents for severe asthma: A systematic review.
    PLoS One. 2021;16:e0257765.
    PubMed     Abstract available


  84. MAROTEAU C, Espuela-Ortiz A, Herrera-Luis E, Srinivasan S, et al
    LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
    PLoS One. 2021;16:e0257396.
    PubMed     Abstract available


  85. ALTAWALBEH SM, Hijazi B, Kufoof L, Basheti IA, et al
    Health expenditures of asthma-COPD overlap in Northern Jordan.
    PLoS One. 2021;16:e0257566.
    PubMed     Abstract available


  86. HSU YL, Lin CL, Wei CC
    Association between vesicoureteral reflux, urinary tract infection and antibiotics exposure in infancy and risk of childhood asthma.
    PLoS One. 2021;16:e0257531.
    PubMed     Abstract available


  87. BAMFORTH RJ, Chhibba R, Ferguson TW, Sabourin J, et al
    Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249542.
    PubMed     Abstract available


  88. KENMOE S, Bowo-Ngandji A, Kengne-Nde C, Ebogo-Belobo JT, et al
    Association between early viral LRTI and subsequent wheezing development, a meta-analysis and sensitivity analyses for studies comparable for confounding factors.
    PLoS One. 2021;16:e0249831.
    PubMed     Abstract available


  89. GILLIAM EA, Cheung T, Kraemer K, Litrownik D, et al
    The impact of Tai Chi and mind-body breathing in COPD: Insights from a qualitative sub-study of a randomized controlled trial.
    PLoS One. 2021;16:e0249263.
    PubMed     Abstract available


  90. GONZALEZ FJ, Alvarez E, Moreno P, Poveda D, et al
    The influence of the native lung on early outcomes and survival after single lung transplantation.
    PLoS One. 2021;16:e0249758.
    PubMed     Abstract available


  91. ONISHI Y, Kawamura T, Higashino T, Mimura R, et al
    Clinical features of acute fibrinous and organizing pneumonia: An early histologic pattern of various acute inflammatory lung diseases.
    PLoS One. 2021;16:e0249300.
    PubMed     Abstract available


  92. OVASKAINEN K, Ojala R, Gissler M, Luukkaala T, et al
    Is birth out-of-hospital associated with mortality and morbidity by seven years of age?
    PLoS One. 2021;16:e0250163.
    PubMed     Abstract available


  93. CHIU YC, Lee SW, Liu CW, Lin RC, et al
    Comprehensive profiling of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity.
    PLoS One. 2021;16:e0249944.
    PubMed     Abstract available


  94. DAWICKI W, Huang H, Ma Y, Town J, et al
    CD40 signaling augments IL-10 expression and the tolerogenicity of IL-10-induced regulatory dendritic cells.
    PLoS One. 2021;16:e0248290.
    PubMed     Abstract available


  95. XIE Z, Sun H, Li X, Sun W, et al
    Alteration of lung tissues proteins in birch pollen induced asthma mice before and after SCIT.
    PLoS One. 2021;16:e0258051.
    PubMed     Abstract available


  96. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed     Abstract available


  97. GE E, Li Y, Wu S, Candido E, et al
    Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    PLoS One. 2021;16:e0258154.
    PubMed     Abstract available


  98. STOFFELS AAF, van den Borst B, Peters JB, Klaassen MPM, et al
    Correlates of variability in endurance shuttle walk test time in patients with chronic obstructive pulmonary disease.
    PLoS One. 2021;16:e0249786.
    PubMed     Abstract available


  99. THAPAMAGAR SB, Ellstrom K, Anholm JD, Fargo RA, et al
    Impact of pulmonary rehabilitation in sleep in COPD patients measured by actigraphy.
    PLoS One. 2021;16:e0248466.
    PubMed     Abstract available


  100. CHANG JT, Meza R, Levy DT, Arenberg D, et al
    Prediction of COPD risk accounting for time-varying smoking exposures.
    PLoS One. 2021;16:e0248535.
    PubMed     Abstract available


  101. CHERNEVA Z, Valev D, Youroukova V, Cherneva R, et al
    Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease - a step forward in cardiovascular comorbidome.
    PLoS One. 2021;16:e0247940.
    PubMed     Abstract available


  102. SHUAI T, Zhang C, Zhang M, Wang Y, et al
    Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251348.
    PubMed     Abstract available


  103. MOHAMED AMINE M, Selma M, Adel S, Khaoula BHA, et al
    2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
    PLoS One. 2021;16:e0251716.
    PubMed     Abstract available


  104. JIANG H, Wu X, Lian S, Zhang C, et al
    Effects of salbutamol on the kinetics of sevoflurane and the occurrence of early postoperative pulmonary complications in patients with mild-to-moderate chronic obstructive pulmonary disease: A randomized controlled study.
    PLoS One. 2021;16:e0251795.
    PubMed     Abstract available


  105. GOFFIN JR, Corriveau S, Tang GH, Pond GR, et al
    Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system.
    PLoS One. 2021;16:e0251886.
    PubMed     Abstract available


  106. HOSKOVEC L, Benka-Coker W, Severson R, Magzamen S, et al
    Model choice for estimating the association between exposure to chemical mixtures and health outcomes: A simulation study.
    PLoS One. 2021;16:e0249236.
    PubMed     Abstract available


  107. LEE J, Lee SH, Gu GJ, Choi JH, et al
    Alterations of lung microbial communities in obese allergic asthma and metabolic potential.
    PLoS One. 2021;16:e0256848.
    PubMed     Abstract available


  108. LAUNAY T, Souty C, Vilcu AM, Turbelin C, et al
    Common communicable diseases in the general population in France during the COVID-19 pandemic.
    PLoS One. 2021;16:e0258391.
    PubMed     Abstract available


  109. ABDUR REHMAN N, Counts S
    Neighborhood level chronic respiratory disease prevalence estimation using search query data.
    PLoS One. 2021;16:e0252383.
    PubMed     Abstract available


  110. NACERADSKA M, Pekova S, Danesi P, Furlanello T, et al
    A novel Filobacterium sp can cause chronic bronchitis in cats.
    PLoS One. 2021;16:e0251968.
    PubMed     Abstract available


  111. HSIEH HY, Huang LC, Yu HR, Kuo KC, et al
    Pediatric thalassemic patients have higher incidence of asthma: A nationwide population-based retrospective cohort study.
    PLoS One. 2021;16:e0258727.
    PubMed     Abstract available


  112. KARAPETYAN S, Schneider A, Linde K, Donnachie E, et al
    SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: A risk assessment based on routine data.
    PLoS One. 2021;16:e0258914.
    PubMed     Abstract available


  113. WICHER SA, Roos BB, Teske JJ, Fang YH, et al
    Aging increases senescence, calcium signaling, and extracellular matrix deposition in human airway smooth muscle.
    PLoS One. 2021;16:e0254710.
    PubMed     Abstract available


  114. NIEMEIER-WALSH C, Ryan PH, Meller J, Ollberding NJ, et al
    Exposure to traffic-related air pollution and bacterial diversity in the lower respiratory tract of children.
    PLoS One. 2021;16:e0244341.
    PubMed     Abstract available


  115. TOUNSI B, Acheche A, Lelard T, Tabka Z, et al
    Effects of specific inspiratory muscle training combined with whole-body endurance training program on balance in COPD patients: Randomized controlled trial.
    PLoS One. 2021;16:e0257595.
    PubMed     Abstract available


  116. FU X, Zhong Y, Xu W, Ju J, et al
    The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: A meta-analysis and systematic review.
    PLoS One. 2021;16:e0256480.
    PubMed     Abstract available


  117. HANSEN WAH, Schlunssen V, Jors E, Sekabojja D, et al
    Precision and accuracy of FEV1 measurements from the Vitalograph copd-6 mini-spirometer in a healthy Ugandan population.
    PLoS One. 2021;16:e0253319.
    PubMed     Abstract available


  118. ROH JA, Kim KI, Jung HJ
    The efficacy of manual therapy for chronic obstructive pulmonary disease: A systematic review.
    PLoS One. 2021;16:e0251291.
    PubMed     Abstract available


  119. NOORT BAC, van der Vaart T, Ahaus K
    Orchestration versus bookkeeping: How stakeholder pressures drive a healthcare purchaser's institutional logics.
    PLoS One. 2021;16:e0258337.
    PubMed     Abstract available


  120. GILLENWATER LA, Helmi S, Stene E, Pratte KA, et al
    Multi-omics subtyping pipeline for chronic obstructive pulmonary disease.
    PLoS One. 2021;16:e0255337.
    PubMed     Abstract available


  121. HALNER A, Beer S, Pullinger R, Bafadhel M, et al
    Predicting treatment outcomes following an exacerbation of airways disease.
    PLoS One. 2021;16:e0254425.
    PubMed     Abstract available


  122. RORTH R, Clausen MF, Fosbol EL, Mogensen UM, et al
    Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
    PLoS One. 2021;16:e0255364.
    PubMed     Abstract available


  123. GIMENO-MIGUEL A, Bliek-Bueno K, Poblador-Plou B, Carmona-Pirez J, et al
    Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study.
    PLoS One. 2021;16:e0259822.
    PubMed     Abstract available


  124. JIANG Y, Hu H, Leung SW
    Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis.
    PLoS One. 2021;16:e0255545.
    PubMed     Abstract available


  125. BOZIGAR M, Lawson AB, Pearce JL, Svendsen ER, et al
    Using Bayesian time-stratified case-crossover models to examine associations between air pollution and "asthma seasons" in a low air pollution environment.
    PLoS One. 2021;16:e0260264.
    PubMed     Abstract available


  126. MACHADO-ALBA JE, Valladales-Restrepo LF, Machado-Duque ME, Gaviria-Mendoza A, et al
    Factors associated with admission to the intensive care unit and mortality in patients with COVID-19, Colombia.
    PLoS One. 2021;16:e0260169.
    PubMed     Abstract available


  127. MONTEIRO KS, Santino TA, Pakhale S, Balfour L, et al
    Translation, cross-cultural adaptation and psychometric evaluation of the Brazilian version of the Cystic Fibrosis Knowledge Scale (CFKS).
    PLoS One. 2021;16:e0259232.
    PubMed     Abstract available


  128. HAKIZIMANA B, Kalimba E, Ndatinya A, Saint G, et al
    Field testing two existing, standardized respiratory severity scores (LIBSS and ReSViNET) in infants presenting with acute respiratory illness to tertiary hospitals in Rwanda - a validation and inter-rater reliability study.
    PLoS One. 2021;16:e0258882.
    PubMed     Abstract available


  129. MEKANIMITDEE P, Morasert T, Patumanond J, Phinyo P, et al
    The MAGENTA model for individual prediction of in-hospital mortality in chronic obstructive pulmonary disease with acute exacerbation in resource-limited countries: A development study.
    PLoS One. 2021;16:e0256866.
    PubMed     Abstract available


  130. LIAO P, Vajdic C, Trollor J, Reppermund S, et al
    Prevalence and incidence of physical health conditions in people with intellectual disability - a systematic review.
    PLoS One. 2021;16:e0256294.
    PubMed     Abstract available


  131. AGUILANIU B, Hess D, Kelkel E, Briault A, et al
    A machine learning approach to predict extreme inactivity in COPD patients using non-activity-related clinical data.
    PLoS One. 2021;16:e0255977.
    PubMed     Abstract available


  132. ADLER D, Bailly S, Soccal PM, Janssens JP, et al
    Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry.
    PLoS One. 2021;16:e0256230.
    PubMed     Abstract available


  133. PERCOPO CM, McCullough M, Limkar AR, Druey KM, et al
    Impact of controlled high-sucrose and high-fat diets on eosinophil recruitment and cytokine content in allergen-challenged mice.
    PLoS One. 2021;16:e0255997.
    PubMed     Abstract available


  134. KIM IS, Choi YJ, Choi EY, Min PK, et al
    Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
    PLoS One. 2021;16:e0258770.
    PubMed     Abstract available


  135. DDUNGU A, Semitala FC, Castelnuovo B, Sekaggya-Wiltshire C, et al
    Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country.
    PLoS One. 2021;16:e0256121.
    PubMed     Abstract available


  136. PEREZ CHACON G, Fathima P, Jones M, Barnes R, et al
    Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.
    PLoS One. 2021;16:e0260388.
    PubMed     Abstract available


  137. RIMMER C, Hetelekides S, Eliseeva SI, Georas SN, et al
    Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge.
    PLoS One. 2021;16:e0260706.
    PubMed     Abstract available


  138. QADEER A, Parikh PB, Ramkishun CA, Tai J, et al
    Impact of chronic obstructive pulmonary disease on survival and neurologic outcomes in adults with in-hospital cardiac arrest.
    PLoS One. 2021;16:e0259698.
    PubMed     Abstract available


  139. STAVEM K, Johannessen A, Nielsen R, Gulsvik A, et al
    Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time.
    PLoS One. 2021;16:e0260416.
    PubMed     Abstract available


  140. KERAMAT SA, Alam K, Rana RH, Chowdhury R, et al
    Obesity and the risk of developing chronic diseases in middle-aged and older adults: Findings from an Australian longitudinal population survey, 2009-2017.
    PLoS One. 2021;16:e0260158.
    PubMed     Abstract available


  141. SPILLING CA, Dhillon MK, Burrage DR, Ruickbie S, et al
    Factors affecting brain structure in smoking-related diseases: Chronic Obstructive Pulmonary Disease (COPD) and coronary artery disease.
    PLoS One. 2021;16:e0259375.
    PubMed     Abstract available


  142. SANDER B, Finkelstein Y, Lu H, Nagamuthu C, et al
    Healthcare cost attributable to bronchiolitis: A population-based cohort study.
    PLoS One. 2021;16:e0260809.
    PubMed     Abstract available


  143. LEE MF, Chiang CH, Lin SJ, Wu CS, et al
    Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.
    PLoS One. 2021;16:e0261333.
    PubMed     Abstract available


  144. CHEN H, Liu X, Gao X, Lv Y, et al
    Epidemiological evidence relating risk factors to chronic obstructive pulmonary disease in China: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0261692.
    PubMed     Abstract available


  145. NAKAMA C, Tabuchi T
    Use of heated tobacco products by people with chronic diseases: The 2019 JASTIS study.
    PLoS One. 2021;16:e0260154.
    PubMed     Abstract available


  146. GOTTLIEB J, Verleden GM, Perchl M, Valtin C, et al
    Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
    PLoS One. 2021;16:e0260881.
    PubMed     Abstract available


    January 2020
  147. CRAIG LS, Hotchkiss DR, Theall KP, Cunningham-Myrie C, et al
    Prevalence and patterns of multimorbidity in the Jamaican population: A comparative analysis of latent variable models.
    PLoS One. 2020;15:e0236034.
    PubMed     Abstract available


  148. BINACHON A, Grateau A, Allou N, Ferdynus C, et al
    Acute severe asthma requiring invasive mechanical ventilation in the era of modern resuscitation techniques: A 10-year bicentric retrospective study.
    PLoS One. 2020;15:e0240063.
    PubMed     Abstract available


  149. BOND EG, Abrahamyan L, Khan MKA, Gershon A, et al
    Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study.
    PLoS One. 2020;15:e0236559.
    PubMed     Abstract available


  150. HARRIS C, Bisquera A, Zivanovic S, Lunt A, et al
    Postnatal dexamethasone exposure and lung function in adolescents born very prematurely.
    PLoS One. 2020;15:e0237080.
    PubMed     Abstract available


  151. MORENO ACR, Nai GA, Laurindo CP, Gregorio KCR, et al
    Resistance training prevents right ventricle hypertrophy in rats exposed to secondhand cigarette smoke.
    PLoS One. 2020;15:e0236988.
    PubMed     Abstract available


  152. BLONDEEL A, Demeyer H, Janssens W, Troosters T, et al
    Accuracy of consumer-based activity trackers as measuring tool and coaching device in patients with COPD and healthy controls.
    PLoS One. 2020;15:e0236676.
    PubMed     Abstract available


  153. CERIOTTI S, Bullone M, Leclere M, Ferrucci F, et al
    Severe asthma is associated with a remodeling of the pulmonary arteries in horses.
    PLoS One. 2020;15:e0239561.
    PubMed     Abstract available


  154. MAHONEY K, Pierce J, Papo S, Imran H, et al
    Efficacy of adding activity of daily living simulation training to traditional pulmonary rehabilitation on dyspnea and health-related quality-of-life.
    PLoS One. 2020;15:e0237973.
    PubMed     Abstract available


  155. BAE K, Ha JY, Jeon KN
    Pneumothorax after CT-guided transthoracic lung biopsy: A comparison between immediate and delayed occurrence.
    PLoS One. 2020;15:e0238107.
    PubMed     Abstract available


  156. BEDARD A, Carsin AE, Fuertes E, Accordini S, et al
    Physical activity and lung function-Cause or consequence?
    PLoS One. 2020;15:e0237769.
    PubMed     Abstract available


  157. MEYBURG J, Ries M
    Decision-making in acute viral bronchiolitis: A universal guideline and a publication gap.
    PLoS One. 2020;15:e0237801.
    PubMed     Abstract available


  158. MEGA TA, Anbese ZK, Yoo SD
    Mortality and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory diseases in Jimma Medical Center; Jimma, Ethiopia: Prospective observational study.
    PLoS One. 2020;15:e0239055.
    PubMed     Abstract available


  159. DEWAN K, Berke GS, Chhetri DK
    Lessons learned from open laryngotracheal airway resection and primary anastomosis in high risk patients.
    PLoS One. 2020;15:e0238426.
    PubMed     Abstract available


  160. JUNGER C, Reimann M, Krabbe L, Gaede KI, et al
    Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis.
    PLoS One. 2020;15:e0238619.
    PubMed     Abstract available


  161. PARIKH TJ, Stryczek KC, Gillespie C, Sayre GG, et al
    Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids.
    PLoS One. 2020;15:e0238511.
    PubMed     Abstract available


  162. TERADA-IKEDA C, Kitabatake M, Hiraku A, Kato K, et al
    Maternal supplementation with Bifidobacterium breve M-16V prevents their offspring from allergic airway inflammation accelerated by the prenatal exposure to an air pollutant aerosol.
    PLoS One. 2020;15:e0238923.
    PubMed     Abstract available


  163. SIDDALL H, Quint D, Pandya H, Powley W, et al
    Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
    PLoS One. 2020;15:e0240964.
    PubMed     Abstract available


  164. PANEK MG, Karbownik MS, Kuna PB
    Comparative analysis of clinical, physiological, temperamental and personality characteristics of elderly subjects and young subjects with asthma.
    PLoS One. 2020;15:e0241750.
    PubMed     Abstract available


  165. SUMIT AF, Das A, Miraj IH, Bhowmick D, et al
    Association between chronic obstructive pulmonary disease (COPD) and occupational exposures: A hospital based quantitative cross-sectional study among the Bangladeshi population.
    PLoS One. 2020;15:e0239602.
    PubMed     Abstract available


  166. COCCO MP, White E, Xiao S, Hu D, et al
    Asthma and its relationship to mitochondrial copy number: Results from the Asthma Translational Genomics Collaborative (ATGC) of the Trans-Omics for Precision Medicine (TOPMed) program.
    PLoS One. 2020;15:e0242364.
    PubMed     Abstract available


  167. KENMOE S, Kengne-Nde C, Ebogo-Belobo JT, Mbaga DS, et al
    Systematic review and meta-analysis of the prevalence of common respiratory viruses in children < 2 years with bronchiolitis in the pre-COVID-19 pandemic era.
    PLoS One. 2020;15:e0242302.
    PubMed     Abstract available


  168. ANBESSE ZK, Mega TA, Tesfaye BT, Negera GZ, et al
    Early readmission and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory disease in Ethiopia: A prospective cohort study.
    PLoS One. 2020;15:e0239665.
    PubMed     Abstract available


  169. WU MC, Jan MS, Chiou JY, Wang YH, et al
    Constipation might be associated with risk of allergic rhinitis: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0239723.
    PubMed     Abstract available


  170. MOGENSEN I, Jacinto T, Alving K, Fonseca JA, et al
    Inflammatory patterns in fixed airflow obstruction are dependent on the presence of asthma.
    PLoS One. 2020;15:e0243109.
    PubMed     Abstract available


  171. MARQUEZ-VELARDE G
    The paradox does not fit all: Racial disparities in asthma among Mexican Americans in the U.S.
    PLoS One. 2020;15:e0242855.
    PubMed     Abstract available


  172. RAMAKRISHNAN RK, Bajbouj K, Hachim MY, Mogas AK, et al
    Enhanced mitophagy in bronchial fibroblasts from severe asthmatic patients.
    PLoS One. 2020;15:e0242695.
    PubMed     Abstract available


  173. KOLIN DA, Kulm S, Christos PJ, Elemento O, et al
    Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank.
    PLoS One. 2020;15:e0241264.
    PubMed     Abstract available


  174. AHETO JMK, Udofia EA, Kallson E, Mensah G, et al
    Prevalence, socio-demographic and environmental determinants of asthma in 4621 Ghanaian adults: Evidence from Wave 2 of the World Health Organization's study on global AGEing and adult health.
    PLoS One. 2020;15:e0243642.
    PubMed     Abstract available


  175. DAVIES G, Jordan S, Thayer D, Tucker D, et al
    Medicines prescribed for asthma, discontinuation and perinatal outcomes, including breastfeeding: A population cohort analysis.
    PLoS One. 2020;15:e0242489.
    PubMed     Abstract available


  176. LIN CH, Tseng CY, Chao MW
    Administration of Lactobacillus paracasei HB89 mitigates PM2.5-induced enhancement of inflammation and allergic airway response in murine asthma model.
    PLoS One. 2020;15:e0243062.
    PubMed     Abstract available


  177. ONO M, Kobayashi S, Hanagama M, Ishida M, et al
    Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: A cross-sectional study.
    PLoS One. 2020;15:e0239764.
    PubMed     Abstract available


  178. SOTO-RUBIO A, Valero-Moreno S, Diaz JL, Andreu Y, et al
    COPD at the end of life: Predictors of the emotional distress of patients and their family caregivers.
    PLoS One. 2020;15:e0240821.
    PubMed     Abstract available


  179. BAN GY, Youn DY, Ye YM, Park HS, et al
    Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease.
    PLoS One. 2020;15:e0240334.
    PubMed     Abstract available


  180. SUN Y, Wang R, Tang W, Li C, et al
    Trends and factors of botanical dietary supplement use among US adults with COPD from 1999 to 2016.
    PLoS One. 2020;15:e0239674.
    PubMed     Abstract available


  181. NASCIMENTO MS, Baggio DM, Fascina LP, do Prado C, et al
    Impact of social isolation due to COVID-19 on the seasonality of pediatric respiratory diseases.
    PLoS One. 2020;15:e0243694.
    PubMed     Abstract available


  182. MARTIN MJ, Zain NMM, Hearson G, Rivett DW, et al
    The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids.
    PLoS One. 2020;15:e0244681.
    PubMed     Abstract available


  183. SKAABY S, Flachs EM, Lange P, Schlunssen V, et al
    Occupational exposures and exacerbations of asthma and COPD-A general population study.
    PLoS One. 2020;15:e0243826.
    PubMed     Abstract available


  184. YADAV UN, Thapa TB, Mistry SK, Ghimire S, et al
    Biosocial and disease conditions are associated with good quality of life among older adults in rural eastern Nepal: Findings from a cross-sectional study.
    PLoS One. 2020;15:e0242942.
    PubMed     Abstract available


  185. ITO Y, Oshinden K, Kutsuzawa N, Kohno C, et al
    Heat-Not-Burn cigarette induces oxidative stress response in primary rat alveolar epithelial cells.
    PLoS One. 2020;15:e0242789.
    PubMed     Abstract available


  186. BARENFELD E, Ali L, Wallstrom S, Fors A, et al
    Becoming more of an insider: A grounded theory study on patients' experience of a person-centred e-health intervention.
    PLoS One. 2020;15:e0241801.
    PubMed     Abstract available


  187. BARROS CF, Felisberto RM, Nucci KCA, Albuquerque ALP, et al
    Dynamic hyperinflation induced by the 6-minute pegboard and ring test in hospitalized patients with exacerbated COPD.
    PLoS One. 2020;15:e0241639.
    PubMed     Abstract available


  188. FLEMING M, McLay JS, Clark D, King A, et al
    Health, educational and employment outcomes among children treated for a skin disorder: Scotland-wide retrospective record linkage cohort study of 766,244 children.
    PLoS One. 2020;15:e0243383.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: